MR Imaging of Middle Cerebellar Peduncle Width: Differentiation of Multiple System Atrophy from Parkinson Disease

Purpose: To prospectively assess if middle cerebellar peduncle (MCP) atrophy, evaluated at magnetic resonance (MR) imaging, can help differentiate multiple system atrophy (MSA) from Parkinson disease (PD).

Materials and Methods: All participants provided informed consent for participation in the study, which was approved by the institutional review board. Sixteen consecutive patients with MSA, 26 consecutive patients with PD, and 14 healthy control subjects were examined with MR imaging. Images were interpreted independently by two experienced neuroradiologists blinded to clinical information, who visually inspected the images for the presence or absence of putaminal atrophy, putaminal hypointensity, slitlike hyperintensity in the posterolateral margin of the putamen, brainstem atrophy, hyperintensity of the MCP, and cruciform hyperintensity of the pons. Measurements of MCP width on T1-weighted volumetric spoiled gradient-echo images were performed in all subjects. Differences in MCP width among the groups were evaluated by using the Kruskall-Wallis test, followed by the Mann-Whitney U test for multiple comparisons and Bonferroni correction.

Results: All patients (mean age, 63.88 years; range, 55–72 years) with MSA had at least one of the features commonly observed in this disease on MR images, whereas control subjects (mean age, 66.93 years; range, 61–77 years) and all but one patient with PD (mean age, 65.31 years; range, 51–79 years) had normal MR images. The average MCP width was significantly smaller in patients with MSA (6.10 mm ± 1.18 [standard deviation]) than in those with PD (9.32 mm ± 0.77, P < .001) or control subjects (9.80 mm ± 0.66, P < .001).

Conclusion: Measurement of MCP width on MR images may be useful for distinguishing patients with MSA from those with PD.

© RSNA, 2006

References

  • 1 Wenning GK, Colosimo C, Geser F, et al. Multiple system atrophy. Lancet Neurol 2004; 3: 93–103. Crossref, MedlineGoogle Scholar
  • 2 Wenning GK, Ben Shlomo Y, Magalhaes M, Daniel SE, Quinn NP. Clinical features and natural history of multiple system atrophy: an analysis of 100 cases. Brain 1994;117:835–845. Crossref, MedlineGoogle Scholar
  • 3 Schrag A, Good CD, Miszkiel K, et al. Differentiation of atypical parkinsonian syndromes with routine MRI. Neurology 2000;54:697–702. Crossref, MedlineGoogle Scholar
  • 4 Schulz JB, Klockgether T, Petersen D, et al. Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT. J Neurol Neurosurg Psychiatry 1994;57:1047–1056. Crossref, MedlineGoogle Scholar
  • 5 van Royen E, Verhoeff NF, Speelman JD, et al. Multiple system atrophy and progressive supranuclear palsy: diminished striatal D2 dopamine receptor activity demonstrated by 123I-IBZM single photon emission computed tomography. Arch Neurol 1993;50:513–516. Crossref, MedlineGoogle Scholar
  • 6 Schwarz J, Tatsch K, Arnold G, et al. 123I-iodobenzamide-SPECT predicts dopaminergic responsiveness in patients with de novo parkinsonism. Neurology 1992;42:556–561. Crossref, MedlineGoogle Scholar
  • 7 Burn DJ, Sawle GV, Brooks DJ. Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data. J Neurol Neurosurg Psychiatry 1994;57:278–284. Crossref, MedlineGoogle Scholar
  • 8 Brooks DJ, Ibanez V, Sawle GV, et al. Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography. Ann Neurol 1992;31:184–192. Crossref, MedlineGoogle Scholar
  • 9 Davie CA, Wenning GK, Barker GJ, et al. Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy. Ann Neurol 1995;37:204–210. Crossref, MedlineGoogle Scholar
  • 10 Dickson DW, Lin W, Liu WK, et al. Multiple system atrophy: a sporadic synucleinopathy. Brain Pathol 1999;9:721–732. Crossref, MedlineGoogle Scholar
  • 11 Wenning GK, Tison F, Elliott L, et al. Olivopontocerebellar pathology in multiple system atrophy. Mov Disord 1996;11:157–162. Crossref, MedlineGoogle Scholar
  • 12 Calne DB, Snow BJ, Lee C. Criteria for diagnosing Parkinson's disease. Ann Neurol 1992;32(suppl 1):S125–S127. Crossref, MedlineGoogle Scholar
  • 13 Gilman S, Low PA, Quinn N, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 1999;163:94–98. Crossref, MedlineGoogle Scholar
  • 14 Armitage P, Berry G, Matthews JNS. Statistical methods in medical research. 4th ed. London, England: Blackwell, 2002. Google Scholar
  • 15 Yekhlef F, Ballan G, Macia F, et al. Routine MRI for the differential diagnosis of Parkinson's disease MSA, PSP, and CBD. J Neural Transm 2003;110:151–169. Crossref, MedlineGoogle Scholar
  • 16 Bhattacharya K, Saadia D, Eisenkraft B, et al. Brain magnetic resonance imaging in multiple-system atrophy and Parkinson disease: a diagnostic algorithm. Arch Neurol 2002;59:835–842. Crossref, MedlineGoogle Scholar
  • 17 Savoiardo M, Strada L, Girotti F, et al. Olivopontocerebellar atrophy: MR diagnosis and relationship to multisystem atrophy. Radiology 1990;174:693–696. LinkGoogle Scholar
  • 18 Yekhlef F, Ballan G, Macia F, et al. Differentiation of atypical parkinsonian syndromes with routine MRI. Neurology 2000;55:1239–1240. CrossrefGoogle Scholar
  • 19 Kraft E, Trenkwalder C, Auer DP. T2*-weighted MRI differentiates multiple system atrophy from Parkinson's disease. Neurology 2002;59:1265–1267. Crossref, MedlineGoogle Scholar
  • 20 Schocke MF, Seppi K, Esterhammer R, et al. Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD. Neurology 2002;58:575–580. Crossref, MedlineGoogle Scholar
  • 21 Kanazawa M, Shimohata T, Terajima K, et al. Quantitative evaluation of brainstem involvement in multiple system atrophy by diffusion-weighted MRI. J Neurol 2004;251:1121–1124. MedlineGoogle Scholar
  • 22 Schulz JB, Skalej M, Wedekind D, et al. Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy. Ann Neurol 1999;45:65–74. Crossref, MedlineGoogle Scholar
  • 23 Schrag A, Kingsley D, Phatouros C, et al. Clinical usefulness of magnetic resonance imaging in multiple system atrophy. J Neurol Neurosurg Psychiatry 1998;65:65–71. Crossref, MedlineGoogle Scholar
  • 24 Murata Y, Yamaguchi S, Kawakami H, et al. Characteristic magnetic resonance imaging findings in Machado-Joseph disease. Arch Neurol 1998;55:33–37. Crossref, MedlineGoogle Scholar
  • 25 Warmuth-Metz M, Naumann M, Csoti I, et al. Measurement of the midbrain diameter on routine magnetic resonance imaging: a simple and accurate method of differentiating between Parkinson disease and progressive supranuclear palsy. Arch Neurol 2001;58:1076–1079. Crossref, MedlineGoogle Scholar

Article History

Published in print: June 2006